33 States to Get $62 Million in Zyprexa Case Settlement

Eli Lilly has agreed to pay $62 million to 33 states to settle claims that it improperly marketed Zyprexa, its top-selling drug, to patients who did not have schizophrenia or bipolar disorder, its only approved uses.

Illinois will receive nearly $3.6 million in settlement funds from the company. Missouri will receive $1.5 million.

Lilly also agreed to several mandates that will last until 2014, well beyond the expiration of Zyprexa’s patent in 2011. The company agreed to avoid making false, misleading or deceptive claims about the drug and not to promote it outside FDA-approved uses.

Posted in Big Muddy River Newsletter, Press Releases | Comments Off on 33 States to Get $62 Million in Zyprexa Case Settlement

MENTAL HEALTH DAY VIGIL FOR THE THOUSANDS OF CHILDREN KILLED BY PSYCHIATRIC DRUGS

Calls to Prohibit Mental Health Screening in Schools

On the eve of Mental Health Day (October 10, 2008), a candlelight vigil was held in the University City Loop in St. Louis in memory of the thousands of children that have died from psychiatric drugs. An estimated 1,340 under-18-year-olds die each year in the United States from psychiatric drug use. Large photos of children at the Vigil were testimony to the many tragic deaths. In recent years, the Food and Drug Administration has increased its warnings about these drugs causing psychosis, suicide, stroke, heart attacks, life threatening diabetes and death.

The Citizens Commission on Human Rights, a psychiatric watchdog and human rights advocacy group that organized the vigil, says that mental health screening of students has exacerbated the problem, often wrongly identifying children as “mentally ill,” resulting in their being prescribed these drugs. Currently, there is a federal initiative to screen all 52 million American schoolchildren for mental disorders that could dramatically increase the number of children placed at risk with psychotropics.

People viewing the Vigil signed a Proclamation that calls on the State Department of Education to jettison psychological and psychiatric screening from their schools and for the state government to reallocate funding for such screening to educational, non-drug programs and additional teachers or tutors.

One screening program, TeenScreen, has an admitted 84 percent failure rate by wrongly identifying children as depressed or potentially suicidal that can lead to their being prescribed antidepressants that can induce suicidal thoughts and actions.
CCHR spokesperson Teresa Hassler said, “All the symptoms listed in the ‘Screen Information Form’ are extracted from those listed in the American Psychiatric Association’s (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM), a manual criticized for its lack of reliability and conflict of interest with the pharmaceutical industry.”

A 2006 study published in Psychotherapy and Psychosomatics determined that psychiatric drug makers funded 100% of the DSM Task Force members that decided what “mood” and “psychotic” disorders were included in the DSM. This year, the Senate Select Finance Committee called on the APA to hand over its financial records relating to pharmaceutical companies. At least 30% of the APA’s income derives from drug makers.

Ms. Hassler said, “Around the world we are holding vigils as a reminder and warning that children are dying from psychotropic drugs that are often pushed through schools. The heavy reliance upon screening here is likely a major factor.” According to a study published in the September issue of the British-based journal BioMed Central, youngsters in the U.S. are three times likelier to be prescribed antidepressants and stimulants and twice as likely to be prescribed antipsychotic drugs, than counterparts in European countries such as Germany and the Netherlands.

Between 1995 and 2002, prescriptions of antipsychotics for children aged 2 to 18 leaped fivefold—from just under half a million to about 2.5 million. In 2003, the FDA warned that antipsychotic drugs could cause diabetes and blood-sugar abnormalities, after 45 child deaths had been reported.

Last year, The New York Times also pointed to the fact that psychiatrists top the list in drug maker gifts that influences drug prescription trends. In Minnesota it was determined that psychiatrists who received at least $5,000 from makers of newer-generation antipsychotic drugs wrote, on average, three times as many prescriptions to children for these than psychiatrist who received less money or none.

In Vermont, drug-company payments to psychiatrists more than doubled from $20,835 in 2005 to an average of $45,692 in 2006. State Attorney General Bill Sorrell stated, “It is particularly troubling that the industry is paying large sums of money to influence prescribing practices involving psychiatric drugs.”

Unlike for most medical conditions, psychiatrists admit they do not know the cause of or cure for any mental disorder for which they prescribe mind-altering drugs. Dr. Thomas Szasz, professor of psychiatry emeritus at the State University of New York, Health Science Center in Syracuse, New York, says, “There is no blood or other biological test to ascertain the presence or absence of a mental illness, as there is for most bodily diseases.”

Proponents of TeenScreen claim that screening can prevent suicides. However, Robert Whitaker, science writer and author of Mad in America, says, “They’re pulling numbers out of thin air—falsely presuming that this crisis is about lack of access to drugs and calling for government to provide more and more of what many of us believe is the wrong kind of treatment.”

A 2005 study by Dr. David Healy and Graham Aldred from the North Wales Department of Psychological Medicine, Cardiff University, Wales, reported that the studies of the newer antidepressants (Prozac, Zoloft, Effexor etc.) show that they increase the risk of suicide. The FDA has a “black box” on antidepressant packaging warning that the drugs can cause suicidal thoughts and actions in those 24 years of age and under.

Dr. Julian Whitaker, director of the renowned Whitaker Wellness Center in California, advises parents: “First of all, refuse to sign those [screening] consent forms when they come home from your child’s school—if they can’t test them, they can’t drug them.”

CCHR was established in 1969 by the Church of Scientology and the eminent Dr. Thomas Szasz, Professor of Psychiatry Emeritus, State University of New York Health Science Center in Syracuse, New York. It has helped obtain legislation protecting children from potentially lethal psychiatric drugs for 40 years.

Posted in Big Muddy River Newsletter, Press Releases | Comments Off on MENTAL HEALTH DAY VIGIL FOR THE THOUSANDS OF CHILDREN KILLED BY PSYCHIATRIC DRUGS

Drug Regulatory Agency Warnings on psychiatric Drugs

The following is a small sample of drug regulatory agency warnings about psychiatric drug adverse reactions. Many consumers are unaware of these side effects or that they can report such effects to the federal drug regulatory agency.

 

2004:

 

March: The U.S. Food and Drug Administration (FDA) warned that Prozac-like antidepressants (SSRIs) could cause: “Anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, akathisia [severe restlessness that can lead to mania/psychosis], hypomania [abnormal excitement] and mania [exalted feelings, delusions of grandeur].”

 

June:  The FDA ordered that the packaging for the stimulant Adderall include a warning about sudden cardiovascular deaths, especially in children with underlying heart disease.

 

September: The FDA warned that diabetes is a risk for those taking the latest antipsychotic drugs, including Zyprexa.

 

October:  The FDA ordered its strongest “black box” warning to antidepressant packaging, alerting that the drugs could cause suicidal thoughts and actions in children and teenagers.

 

December:  The FDA required that packaging for the “ADHD” drug Strattera carry a new warning advising, “Severe liver damage progress to liver failure resulting in death or the need for a liver transplant in a small percentage of patients.”

 

2005:

 

April: The FDA required a “boxed warning” for packaging of antipsychotic drugs warning of the risk of death in elderly patients with dementia taking them.

 

June: The FDA announced its intention to make labeling changes for Concerta and other stimulants to include, “psychiatric events such as visual hallucinations, suicidal ideation [ideas], psychotic behavior, as well as aggression or violent behavior.”

 

June   The FDA warned that the antidepressant Cymbalta could increase suicidal thinking or behavior in pediatric patients taking the drugs. In October, it also ordered an additional warning of potential liver damage.

 

August: The Australian TGA reported that SSRI antidepressants could cause “new onset of suicidality” in adults and also agitation, nervousness and anxiety. Similar symptoms could occur during withdrawal.

 

August: The European Medicines Agency’s Committee for Medicinal Products issued its strongest warning against pediatric use of antidepressants, stating they could cause suicide attempts and thoughts, aggression, hostility and oppositional behavior and anger.

 

September:  The Agenzia Italiana del Farmaco (Italian drug regulatory agency) ordered a warning label for older type antidepressants advising against use in under 18 year olds; the drugs were also associated with heart attacks in people of any age.

 

October: The FDA withdrew the stimulant Cylert from the market because of its “overall risk of liver toxicity” and liver failure.

 

November:  The FDA approved updated labeling for the antidepressant Effexor ER (extended release), to note it could cause homicidal ideation.

 

December:  Health Canada warned that pregnant women taking Paxil placed their newborn at risk of birth defects.

 

2006:

 

 

February:  The British Medicine and Healthcare Products Regulatory Agency reported the antidepressant Strattera (also used for “ADHD”) was associated with seizures and a potentially dangerous lengthening of time between heartbeats.

 

May:  Health Canada issued new warnings of rare heart risks for all stimulants, such as Ritalin and Adderall, including the risk of sudden death. In August, the FDA ordered a similar warning be added to stimulant drug packaging.

 

July: The FDA warned of the risk of a fatal lung condition in newborns whose mothers took SSRIs during pregnancy.

 

2007:

 

March:  New Zealand urged health professionals to monitor patients on the antipsychotic drug Clozapine after a review found five people had died.

 

May 2: The FDA extended the age group for the black box warning about antidepressants inducing suicide from 18 to 24.

 

June:  The Australian TGA reported a range of cardiac disorders (potentially fatal inflammation of the heart muscle) associated with the use of the antipsychotic, Clozapine.

 

September: The FDA reported a warning was added to the antipsychotic Haldol (haloperidol) about the potential risk of death and dangerous heart conditions observed in some patients.

 

2008:

 

June: The FDA issued a warning that antipsychotics are associated with an increased risk of mortality in elderly patients treated for dementia-related psychosis. It specified that antipsychotics were not indicated for the treatment of this condition and could increase risk of death in some elderly people.

 

 

You are encouraged to report negative side effects of prescription drugs to the FDA.  Visit www.fda.gov/medwatch or call 1-800-FDA-1088.


No one should stop taking any psychiatric drug without the advice and assistance of a competent, non-psychiatric medical doctor.

Posted in Big Muddy River Newsletter, Press Releases | Comments Off on Drug Regulatory Agency Warnings on psychiatric Drugs

Seroquel Litigation: 8,787 Lawsuits Filed against AstraZeneca

September 4th, 2008
http://www.aboutlawsuits.com/seroquel-litigation-8787-lawsuits-filed-against-astrazeneca-955/According to court documents filed last week, AstraZeneca currently faces 8,787 Seroquel lawsuits that have been filed in federal and state courts, which allege that their antipsychotic medication led to personal injuries, such as pancreatitis and diabetes.

Seroquel (generic quetiapine fumarate) is an atypical antipsychotic medication which was approved by the FDA in 1997 for treatment of schizophrenia. It is also commonly used off-label for treatment of anxiety, obsessive dementia, compulsive disorders and autism.

Research has established that Seroquel side effects can increase the risk of weight gain, hyperglycemia and diabetes.

Other drugs in the same class of atypical antipsychotics, which include Zyprexa and Risperdal, have also been associated with these side effects, but the diabetes risk has been the highest in the case of Seroquel.

AstraZeneca indicates that they have been served with complaints involving over 13,000 plaintiff groups. As of August 27, 2008, about 5,841 Seroquel lawsuits have been filed in federal court involving 5,847 plaintiffs, and another 2,946 Seroquel cases have been file in various state courts involving 7,492 more plaintiff groups.

In federal court, the Seroquel litigation has been consolidated in an MDL, or Multidistrict Litigation, that is centralized in the U.S. District Court for the Middle District of Florida before Judge Anne Conway. Approximately 5,829 of the lawsuits are currently in the MDL, where they are being handled together for pretrial proceedings. If the cases do not resolve during pretrial litigation, the MDL procedures require that the cases be sent back to the court where they were filed for trial.

In an attempt to facilitate a resolution of the cases, Judge Conway has established a case management order which calls for the first Seroquel trials involving cases filed in Florida to begin in February 2009. A group of 12 cases have been selected, involving six cases designated and ranked by the Plaintiffs Steering Committee and six by the defendants. The Seroquel litigation will start with the trial of the top ranked case selected by the plaintiffs, and then trials will alternate back and forth until those cases have been tried.

Zyprexa litigation, which involved similar claims of diabetes and weight gain associated with the other type of atypical antipsychotic resolved earlier this year before the first individual injury trials began. Eli Lilly, who manufactures Zyprexa, paid about $1.2 billion in to settle about 30,000 individual Zyprexa lawsuits.

Posted in Big Muddy River Newsletter, Press Releases | Comments Off on Seroquel Litigation: 8,787 Lawsuits Filed against AstraZeneca

PsychRights Sues State of Alaska

http://psychrights.org/PR/080902PsychRightsvAlaskaNR.pdf

NEWS RELEASE

FOR IMMEDIATE RELEASE
CONTACT:
Jim Gottstein
907-274-7686
jim.gottstein@psychrights.org

PsychRights Sues State of Alaska to Stop Its Massive, Harmful Psychiatric Drugging of Alaskan Children

The Law Project for Psychiatric Rights (PsychRights) announced that due to the State of Alaska’s unwillingness, or inability, to enter into substantive talks, it has filed its lawsuit against the State of Alaska and officials responsible for the excessive, ineffective, and extremely harmful psychiatric drugging of Alaskan children and youth.  The lawsuit seeks an injunction stopping the practice of Alaska authorizing or paying for psychotropic drugs to be given children without safeguards being in place to make sure proper decision making occurs.

Jim Gottstein, the president of PsychRights and the attorney bringing the lawsuit, said, “The corrupt influence of the pharmaceutical industry in illegally promoting much of this psychiatric drugging of children has been well established, yet the State of Alaska continues to inflict great harm on the children it has taken away from their families by giving them these drugs.”  It is ludicrous that the State sued a drug company for fraud in hiding the harm caused by one of these drugs and still gives that same drug and other toxic drugs like it, to children.

Dr. Karen Effrem, pediatrician and board member of the Alliance for Human Research Protection (AHRP) and the International Center for the Study of Psychiatry and Psychology (ICSPP), said, “These dangerous and ineffective drugs are tragically overused to merely control behavior of children who are distraught about being taken away from their families.  Missing one’s family or reacting to trauma are wrongly labeled as biological brain disorders that need treatment with powerful medications.  Drugs will not put their families back together or help them overcome their trauma and grief.  These brain and body damaging pharmaceuticals compound the abuse and trauma.  To paraphrase a popular motivational saying, what these kids truly need are ‘hugs, not drugs; hope not dope,’ (even legal dope)”

For those who would like more information, in addition to the Complaint, there is a set of Questions and Answers about the lawsuit and Mr. Gottstein is scheduled to speak October 10th on “Critical ThinkRx and PsychRights’ Lawsuit Against the State of Alaska’s Psychiatric Drugging of Children” at the ICSPP conference being held October 10-12 in Tampa, Florida.

The Law Project for Psychiatric Rights is a public interest law firm devoted to the defense of people facing the horrors of unwarranted forced psychiatric drugging and electroshock. PsychRights is further dedicated to exposing the truth about psychiatric interventions and the courts being misled into ordering people subjected to these brain and body damaging drugs against their will. Extensive information about these dangers, and about the tragic damage caused by electroshock, is available on the PsychRights web site: http://psychrights.org/.

Posted in Big Muddy River Newsletter, Press Releases | Comments Off on PsychRights Sues State of Alaska

PsychRights Launches Pro Bono Recruitment Effort

http://psychrights.org/states/NewYork/080818AnnLNR.pdf

NEWS RELEASE
FOR IMMEDIATE RELEASE
August 18, 2008

CONTACTS:
Dan Hazen
(315) 528-3385
dan@psychrights.orgJim Gottstein
(907) 274-7686

PsychRights Launches Pro Bono Recruitment Effort

As part of their Joint Task Force on Mental Legal Advocacy & Activism, the Law Project for Psychiatric Rights (PsychRights) today announced the launch of its effort to recruit pro bono attorneys to help defend New York citizens facing the horror of forced psychiatric drugging in the community.

PsychRights’ President, Jim Gottstein, said, “People think forced drugging makes the community safer, but the opposite is true. It is well established that psychiatric drugs forced on people increase rather than decrease violence. The idea that forced community psychiatric drugging makes people safer is a fraud perpetrated on the public by organizations like the Treatment Advocacy Center.”

The scientific evidence on this, the ineffectiveness of these drugs for most and extreme harm to all caused by these drugs, along with a legal analysis, has been put together for attorneys in Memorandum (Preliminary) Forced Psychiatric Drugging in the Community –Pro Bono Opportunity of Great Significance. Dan Hazen, PsychRights’ Northeast Coordinator said, “We hope members of the New York bar will read the memorandum and decide this is an issue deserving of pro bono services.” Attorneys interested in signing on or desiring more information may contact either Mr. Hazen or Mr. Gottstein at the contacts above or below.

Mr. Gottstein stated, “If nothing else, attorneys should be offended by the sham nature of the legal proceedings in which New York citizens are ordered by the courts to take these very debilitating, largely ineffective, and extremely harmful drugs.”

The Law Project for Psychiatric Rights is a public interest law firm devoted to the defense of people facing the horrors of unwarranted forced psychiatric drugging and electroshock. PsychRights is further dedicated to exposing the truth about psychiatric interventions and the courts being misled into ordering people subjected to these brain and body damaging drugs against their will. Extensive information about these dangers, and about the tragic damage caused by electroshock, is available on the PsychRights web site http://psychrights.org/.

Posted in Big Muddy River Newsletter, Press Releases | Comments Off on PsychRights Launches Pro Bono Recruitment Effort

Rep. Walorski: Court Ruling is a Victory for Parental Rights

Indiana General Assembly

House of Representatives

News Release

State Rep. Jackie Walorski

Room 401-8, Statehouse

Indianapolis, IN  46204

 

STATEHOUSE (Aug. 7, 2008) — The cause of parental rights and personal liberty won a victory Tuesday (August 5) as a federal court affirmed the right of Hoosier parents to sue a school system for subjecting their daughter to mental health testing without their consent.

The U.S. District Court for the Northern District of Indiana ruled that a lawsuit filed on behalf of Chelsea Rhoades and her parents, Teresa and Michael, may proceed to trial. The family charges that the Penn-Harris-Madison School Corp. violated the family’s rights when school officials subjected Chelsea, a student at Penn High School in Mishawaka, to the TeenScreen examination without parental consent.

“I am elated that the federal court is allowing the family the opportunity to pursue this lawsuit,” said state Rep. Jackie Walorski (R-Jimtown) “This kind of testing without parental consent led me to go on a petition drive that collected more than 12,000 names and eventually resulted in a state law requiring written parental approval before screenings such as this.

“The court, through its ruling, reaffirms parents’ right to control their children’s mental and physical health and wellbeing,” Rep. Walorski said, “and it sends a message to schools and agencies that they should be very, very careful about interfering with parental prerogatives.”

In December 2004, representatives of Madison Mental Health tested Chelsea and other Penn High School students using the TeenScreen, which asks questions that can be answered with only a “Yes” or a “No.” According to the lawsuit, Chelsea was diagnosed as possibly suffering from two mental health disorders. Several other students also were similarly diagnosed, the lawsuit said. Chelsea’s diagnosis turned out to be incorrect.

The Rhoades family is being assisted in the lawsuit by The Rutherford Institute, a civil liberties organization that provides legal services to people whose constitutional rights have been threatened or violated.

Mr. and Mrs. Rhoades said they had no knowledge of the testing until after the fact, and they sued in federal court, charging that their constitutional rights to family integrity and privacy were violated. School officials sought to have the suit dismissed.

“There are boundaries to keep schools and other agencies from interfering in the parent-child relationship,” Rep. Walorski said. “Those boundaries should not be ignored or taken lightly, and this case shines a light on that issue.”

Posted in Big Muddy River Newsletter, Press Releases | Comments Off on Rep. Walorski: Court Ruling is a Victory for Parental Rights

Pharma Funding Controversy Hones In on psychiatry

Vermont AG Calls Heavy Weight of Drug Money Towards Psychiatrists “Troubling”

The psychiatric watchdog, Citizens Commission on Human Rights, says the July 2008 Vermont Attorney General report revealing psychiatrists again top the list of doctors receiving Pharma payments, coupled with recent investigations into Pharma funds influencing psychiatric drug studies, prescribing patterns and the creation of new mental “disorders,” merits a federal investigation for conflicts of interest that is long overdue. The organization created a new website containing recent reports, disclosures, documents and videos exposing the major conflicts of interest between psychiatry and the Pharmaceutical industry called PsychConflicts.org (“psychiatry & pharma – the unholy alliance”).

The July 8, 2008 Vermont Attorney General report on pharmaceutical marketing disclosures revealed that $3 million was spent on drug promotions in Vermont in 2007, with 11 psychiatrists receiving 20% of the total amount, $630,000, a 25% increase from what psychiatrists were paid in 2006. The report also reveals that 7 of the top 10 drugs that companies paid prescribing fees for were psychiatric drugs. An article in the Vermont Rutland Herald, quoted Vermont Attorney General Bill Sorrell, “It is particularly troubling that the industry is paying large sums of money to influence prescribing practices involving psychiatric drugs.” This is the second consecutive year in which Vermont psychiatrists have topped the list. The only other state that requires pharmaceutical companies to disclose payments to doctors, Minnesota, had identical results; psychiatrists received the most pharma funding over all other doctors.

On the federal level, Senate investigators uncovered three industry-shaping psychiatrists who failed to report a combined total of about $7.9 million, two of which were psychiatrists attributed with fuelling widespread child psychiatric drugging. First was Maria DelBello, a child psychiatrist at the Cincinnati Children’s hospital, who failed to report being paid $180,000 from AstraZeneca, manufacturer of the antipsychotic drug Seroquel. According to the New York Times, “Dr. DelBello’s studies of Seroquel in children have helped to fuel the widespread pediatric use of antipsychotic medicines. Those studies were inconclusive, but she has described them as demonstrating that Seroquel is effective in some children.” Second is Dr. Joseph Biederman, a child psychiatrist who also fueled an explosion in the use of powerful antipsychotic drugs in children, who failed to report $1.6 million in consulting fees he earned from drug makers between 2000 and 2007. The third is Alan Schatzberg, who failed to report over $6 million in pharmaceutical stocks and income. Schatzberg is not only chairman of the psychiatry department at Stanford University, but President Elect of the APA, which publishes the Diagnostic and Statistical Manual of Mental Disorders (DSM), also known as the “billing bible” of mental disorders for which the drugs are being prescribed.

Unlike medical diseases, which are discovered through verifiable physical conditions or abnormalities, DSM disorders are invented by codifying key behaviors and repackaging them as diseases, literally voting them into existence by a show of hands from DSM task members. The influence of pharmaceutical funding over these task members in “creating” the disorders was exposed in a 2006 study — 56% of those participating in revising the 1994 DSM had undisclosed financial ties to drug companies. Researchers also found that 100% of the psychiatrists on panels overseeing so-called “mood disorders” (which includes the lucrative “bipolar disorder”) were financially involved with drug companies that manufacture the drugs prescribed for these conditions, the sales of which are around $40 billion a year worldwide. About 30% of the APA income comes from pharmaceutical industry advertising, which has earned over $10 million a year from conflicts within the APA and the pharmaceutical industry. The Washington Post reported that “Last year’s meeting of the American Psychiatric Association…reflects the extent of corporate sponsorships…. Some instructors were sponsored by at least a dozen companies.”

With pharmaceutical conflicts of interest garnering increasing scrutiny, both in the press and in federal investigations, the DSM is increasingly coming under fire. A New York Times article, “Psychiatry Handbook Linked to Drug Industry” reported in March this year that “More than half of the task force members who will oversee the next edition of the American Psychiatric Association’s most important diagnostic handbook have ties to the drug industry.” These ties have created a skyrocketing prescribing rate for psychiatric diagnoses, including a sevenfold increase in “bipolar” diagnoses in the past 13 years, according to a 2007 study.

With federal investigations currently focused on pharmaceutical funds influencing drug approval, drug safety and prescribing habits, CCHR says that psychiatrists creating mental disorders or approving them into psychiatry’s billing bible, the DSM, must be fully investigated for being funded by the drug companies that rely on new mental “disorders” to sell more drugs.

Learn more about the unholy alliance between psychiatry and pharma by visiting PsychConflicts.org.

Posted in Big Muddy River Newsletter, Press Releases | Comments Off on Pharma Funding Controversy Hones In on psychiatry

WATCHDOG SAYS KARADZIC’S ARREST HIGHLIGHTS PSYCHIATRY’S HISTORY OF ETHNIC CLEANSING

The psychiatric watchdog, Citizens Commission on Human Rights (CCHR), says the recent capture (7/21/2008) of former Bosnian Serb leader Radovan Karadzic will bring to justice a psychiatrist whose genocide of thousands was reminiscent of Nazi psychiatric crime during World War II, and that few people are aware that the “ethnic cleansing” ridding a geographical area of racially “inferior” people – carried out in Bosnia-Herzegovina, and later in Kosovo, was based on the same psychiatric-inspired racial hygiene programs that led to the Nazi Holocaust.

In 1992, CCHR formally submitted to the World Psychiatric Association, the World Federation for Mental Health and the Mental Health Division of the World Health Organization information concerning the psychiatric atrocities committed in the region formerly called Yugoslavia.

CCHR presented the same information about psychiatry’s role in initiating and conducting the ethnic cleansing atrocities in Bosnia-Herzegovina to the United Nations Commission on Human Rights.

On September 1, 1999, members of the Council of Europe signed a Resolution, “Human suffering and degradation following ethnic cleansing”, that recognized the two psychiatrists as “the architects of the ethnic cleansing campaign” in Bosnia-Herzegovina, Croatia and Serbia.

The Hague Tribunal indicted Karadzic in absentia in 1995 for genocide over the 43-month siege of Sarajevo that claimed 12,000 lives and orchestrating the 1995 massacre of 8,000 Muslims. Dr. Edward Klain, a psychiatrist and advisor to the Serbian Military who features in a CCHR documentary, Psychiatry: An Industry of Death, detailed how in Nazi Germany it was “technically very difficult” to exterminate six million Jews. Concentration camps and gas chambers need to be established. In Bosnia, hatred and crimes against inhumanity were incited through propaganda: “Serbs would massacre, for example, one hundred to two hundred people. Or rape one hundred women, or one hundred girls, so that they would be terrorized so that they flee. Then you get an ethnically pure land”, Klain said.

CCHR’s evidence showed that Karadzic had trained under former Social Democratic Party (SDP) founder, psychiatrist Jovan Raskovic. Before his death in 1992, Raskovic told Belgrade television and Vjeskik newspaper that he and his party had “lit the fuse of Serbian nationalism” with Freudian principles about inferiority and superiority. Raskovic was talking about his and Karadzic’s propagation that Croats were “fixated on the castration complex”, a Freudian principle, while Muslims were domineering. Serbs, they said, possessed “the qualities of authority” and were destined leaders, while Croats and Muslims were the lesser races that needed to be eliminated. The psychiatrist pushed his Freudian-based theories on the races of Yugoslavia in his book Luda Zemla (A Mad Country) and as part of a media campaign in which he was hailed as the greatest psychiatrist and scientist of his era.

“I feel responsible because I made the preparations for this war, even if not the military preparations. If I hadn’t created this emotional strain in the Serbian people, nothing would have happened”, Raskovic stated.

Other evidence presented to the Hague Tribunal and Council of Europe was that former Serbian president Slobodan Milosevic, who also flamed the conflict against ethnic minorities, had been a patient of Karadzic’s for 25 years. Together, he and Karadzic established the ethnic cleansing program and allowed the mass torture, rape and extermination of the innocent.

CCHR said justice can be served now that the architect of the Bosnian ethnic cleansing has been captured, unlike in Nazi Germany where dozens of psychiatrists responsible for sterilization and genocidal crimes escaped trial and returned to practice in Germany and other countries around the world. Like Karadzic in Bosnia, Ernst Rudin was a psychiatrist who played a major role in setting the stage for the Holocaust. Rudin was president of the International Federation of Eugenic Organizations and world leader of the eugenics movement which sought to remove “inferior” individuals from society by segregation, sterilization, or death in order to create a “better” race. In 1933 Rudin was chosen by Hitler’s Reich Ministry to lead Germany’s racial purity program. Rudin would later publicly praise Hitler for making his “more than thirty-year-old dream a reality” by imposing “racial hygiene” upon the German people.

CCHR president, Jan Eastgate said, “Responsibility exists on all levels, and while the atrocities of ethnic cleansing and genocide are usually what capture our attention, it is important to recognize the ideology that spawns them and to hold those responsible for this to account.”

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , | Comments Off on WATCHDOG SAYS KARADZIC’S ARREST HIGHLIGHTS PSYCHIATRY’S HISTORY OF ETHNIC CLEANSING

CONTROVERSY MOUNTS OVER VOLATILE “MOTHERS ACT” DESPITE DEFEAT OF OMNIBUS BILL

This week, the “MOTHERS Act” — federal bill requiring mental health screening for pregnant women and new mothers which frequently leads to psychiatric drugging — was defeated as part of an omnibus package proposed by Senate Majority Leader Harry Reid. Although the defeat of the MOTHERS Act is a victory for those who oppose it, the controversy over the purpose of the bill and those who back it continues to mount. In an article featuring an exclusive interview with one of the bill’s leading opponents, Mrs. Amy Philo, founder of UNITE (United Non-profits and Individuals for Truth and Ethics), describes in graphic detail her personal experience of becoming violent and suicidal from the antidepressants prescribed to her following the birth of her son and her battle against the vested interests that continue to promote this treatment for new mothers.

 READ THE WORLD NET DAILY EXCLUSIVE WITH MRS. AMY PHILO HERE.   

 

 

Mrs. Philo is not alone in her opposition to a bill which calls for mental health screening designed to get more women on drugs. Grounds for concern regarding the dangers of antidepressants are overwhelming; Between 2002 and 2008, there were more than 64 studies and international drug regulatory warnings on the dangers of antidepressant drugs ranging from from suicidal and homicidal ideation to premature births, spontaneous abortions and birth defects.

In fact according to the FDA’s MedWatch Reporting System, over 700 adverse reactions concerning pregnant women taking newer Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants were reported between 2004 and 2007. Even more alarming is the FDA’s admission that only 1 – 10% of adverse drug reactions are ever reported, so the actual reports are assuredly in the thousands.

 Read more about the controversy over this bill in “Life With Big Brother – Government to Test Moms for Baby Blues?” Click Here. 

 To find out more about the Mothers Act visit http://www.cchr.org/mothers_act.html 

 

 

To find out more about psychiatric drugs visit http://www.cchr.org/psychiatric_drugs

Posted in Big Muddy River Newsletter, Press Releases | Comments Off on CONTROVERSY MOUNTS OVER VOLATILE “MOTHERS ACT” DESPITE DEFEAT OF OMNIBUS BILL